Kimelman & Baird’s Fabrinet FN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-200
Closed -$58.9K 323
2025
Q2
$58.9K Hold
200
﹤0.01% 176
2025
Q1
$39.5K Hold
200
﹤0.01% 207
2024
Q4
$44K Hold
200
﹤0.01% 198
2024
Q3
$47.3K Hold
200
﹤0.01% 193
2024
Q2
$49K Buy
+200
New +$42.4K ﹤0.01% 185
2017
Q4
$1.62M Sell
56,380
-84,600
-60% -$2.8M 0.23% 57
2017
Q3
$5.22M Sell
140,980
-4,020
-3% -$164K 0.78% 39
2017
Q2
$6.19M Buy
145,000
+3,100
+2% +$117K 0.94% 37
2017
Q1
$5.96M Sell
141,900
-3,700
-3% -$154K 0.91% 36
2016
Q4
$5.87M Sell
145,600
-2,350
-2% -$98K 0.98% 33
2016
Q3
$6.6M Buy
+147,950
New +$5.87M 1.16% 31

Other funds holding FN

Kimelman & Baird's FN Position: Q3 2025 in Review

Kimelman & Baird sold out of Fabrinet (FN) in Q3 2025, closing a stake of 200 shares — an estimated $58.9K sold.

Kimelman & Baird first reported a position in FN in Q3 2016 and held it in 11 quarters. The position peaked at $6.6M in Q3 2016. 514 funds tracked by Wall St. Rank hold FN as of Q3 2025.

  • Kimelman & Baird reported no remaining Fabrinet position as of Q3 2025 after selling out during the quarter.
  • Kimelman & Baird sold 200 Fabrinet shares in Q3 2025, an estimated $58.9K.
  • Kimelman & Baird first reported a position in Fabrinet in Q3 2016 and held it in 11 quarters.
  • Kimelman & Baird's Fabrinet position peaked at $6.6M in Q3 2016.
  • 514 funds tracked by Wall St. Rank held Fabrinet as of Q3 2025.

Based on Kimelman & Baird's 13F filing for Q3 2025, filed 25 Nov 2025.